Read More

Billions On The Move: Tracking Market Cap Changes In Top Cannabis Firms After DEA Rescheduling Announcement

Tuesday's announcement that the DEA is moving towards rescheduling cannabis from Schedule I to Schedule III, has already injected billions into the publicly traded market for cannabis companies.

ACB

Read More

Cannabis Stocks React To DEA Rescheduling: Canopy & Aurora Surge, Tilray, WM Tech Hold Steady

In a historic trading session on Tuesday, cannabis stocks soared following the DEA's decision to reclassify marijuana from Schedule I to Schedule III under the Controlled Substances Act.

ACB

Read More

Investors Shuffle Stock Positions In Aurora Cannabis: Beyond Earnings, Liquidity Looks Appealing

Aurora Cannabis Inc. captured investor attention with a dramatic 38% increase in options trading and a significant 18.2% surge in stock price in a single trading day. These movements underscore a robust financial period for the company, which reported quarterly revenues of $53.34 million, surpassing expectations by nearly 16%.

ACB